FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1584230522> ?p ?o ?g. }

• W1584230522 endingPage "15326" @default.
• W1584230522 startingPage "15313" @default.
• W1584230522 abstract "Sialyl Lewis X (sLex) antigen functions as a common carbohydrate determinant recognized by all three members of the selectin family. However, its expression and function in mice remain undefined due to the poor reactivity of conventional anti-sLex monoclonal antibodies (mAbs) with mouse tissues. Here, we developed novel anti-sLex mAbs, termed F1 and F2, which react well with both human and mouse sLex, by immunizing fucosyltransferase (FucT)-IV and FucT-VII doubly deficient mice with 6-sulfo-sLex-expressing cells transiently transfected with an expression vector encoding CMP-N-acetylneuraminic acid hydroxylase. F1 and F2 specifically bound both the N-acetyl and the N-glycolyl forms of sLex as well as 6-sulfo-sLex, a major ligand for L-selectin expressed in high endothelial venules, and efficiently blocked physiological lymphocyte homing to lymph nodes in mice. Importantly, both of the mAbs inhibited contact hypersensitivity responses not only when administered in the L-selectin-dependent sensitization phase but also when administered in the elicitation phase in mice. When administered in the latter phase, F1 and F2 efficiently blocked rolling of mouse leukocytes along blood vessels expressing P- and E-selectin in the auricular skin in vivo. Consistent with these findings, the mAbs blocked P- and E-selectin-dependent leukocyte rolling in a flow chamber assay. Taken together, these results indicate that novel anti-sLex mAbs reactive with both human and mouse tissues, with the blocking ability against leukocyte trafficking mediated by all three selectins, have been established. These mAbs should be useful in determining the role of sLex antigen under physiological and pathological conditions. Sialyl Lewis X (sLex) antigen functions as a common carbohydrate determinant recognized by all three members of the selectin family. However, its expression and function in mice remain undefined due to the poor reactivity of conventional anti-sLex monoclonal antibodies (mAbs) with mouse tissues. Here, we developed novel anti-sLex mAbs, termed F1 and F2, which react well with both human and mouse sLex, by immunizing fucosyltransferase (FucT)-IV and FucT-VII doubly deficient mice with 6-sulfo-sLex-expressing cells transiently transfected with an expression vector encoding CMP-N-acetylneuraminic acid hydroxylase. F1 and F2 specifically bound both the N-acetyl and the N-glycolyl forms of sLex as well as 6-sulfo-sLex, a major ligand for L-selectin expressed in high endothelial venules, and efficiently blocked physiological lymphocyte homing to lymph nodes in mice. Importantly, both of the mAbs inhibited contact hypersensitivity responses not only when administered in the L-selectin-dependent sensitization phase but also when administered in the elicitation phase in mice. When administered in the latter phase, F1 and F2 efficiently blocked rolling of mouse leukocytes along blood vessels expressing P- and E-selectin in the auricular skin in vivo. Consistent with these findings, the mAbs blocked P- and E-selectin-dependent leukocyte rolling in a flow chamber assay. Taken together, these results indicate that novel anti-sLex mAbs reactive with both human and mouse tissues, with the blocking ability against leukocyte trafficking mediated by all three selectins, have been established. These mAbs should be useful in determining the role of sLex antigen under physiological and pathological conditions." @default.
• W1584230522 created "2016-06-24" @default.
• W1584230522 creator A5002261325 @default.
• W1584230522 creator A5003373627 @default.
• W1584230522 creator A5011883647 @default.
• W1584230522 creator A5013168337 @default.
• W1584230522 creator A5021288677 @default.
• W1584230522 creator A5086640700 @default.
• W1584230522 creator A5087133884 @default.
• W1584230522 creator A5089572133 @default.
• W1584230522 date "2015-06-01" @default.
• W1584230522 modified "2023-10-03" @default.
• W1584230522 title "Novel Antibodies Reactive with Sialyl Lewis X in Both Humans and Mice Define Its Critical Role in Leukocyte Trafficking and Contact Hypersensitivity Responses" @default.
• W1584230522 cites W1524483652 @default.
• W1584230522 cites W1967906263 @default.
• W1584230522 cites W1968104539 @default.
• W1584230522 cites W1980516673 @default.
• W1584230522 cites W1991415813 @default.
• W1584230522 cites W1997379663 @default.
• W1584230522 cites W1997984804 @default.
• W1584230522 cites W1999844286 @default.
• W1584230522 cites W2000150629 @default.
• W1584230522 cites W2004432012 @default.
• W1584230522 cites W2006044324 @default.
• W1584230522 cites W2012713768 @default.
• W1584230522 cites W2027498388 @default.
• W1584230522 cites W2029812241 @default.
• W1584230522 cites W2033604747 @default.
• W1584230522 cites W2046065497 @default.
• W1584230522 cites W2047762573 @default.
• W1584230522 cites W2061140050 @default.
• W1584230522 cites W2069193445 @default.
• W1584230522 cites W2080016095 @default.
• W1584230522 cites W2085875957 @default.
• W1584230522 cites W2086818231 @default.
• W1584230522 cites W2087308464 @default.
• W1584230522 cites W2088440984 @default.
• W1584230522 cites W2140449516 @default.
• W1584230522 cites W2145245707 @default.
• W1584230522 cites W2473810120 @default.
• W1584230522 doi "https://doi.org/10.1074/jbc.m115.650051" @default.
• W1584230522 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4463470" @default.
• W1584230522 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25944902" @default.
• W1584230522 hasPublicationYear "2015" @default.
• W1584230522 type Work @default.
• W1584230522 sameAs 1584230522 @default.
• W1584230522 citedByCount "20" @default.
• W1584230522 countsByYear W15842305222016 @default.
• W1584230522 countsByYear W15842305222017 @default.
• W1584230522 countsByYear W15842305222018 @default.
• W1584230522 countsByYear W15842305222019 @default.
• W1584230522 countsByYear W15842305222020 @default.
• W1584230522 countsByYear W15842305222021 @default.
• W1584230522 countsByYear W15842305222022 @default.
• W1584230522 countsByYear W15842305222023 @default.
• W1584230522 crossrefType "journal-article" @default.
• W1584230522 hasAuthorship W1584230522A5002261325 @default.
• W1584230522 hasAuthorship W1584230522A5003373627 @default.
• W1584230522 hasAuthorship W1584230522A5011883647 @default.
• W1584230522 hasAuthorship W1584230522A5013168337 @default.
• W1584230522 hasAuthorship W1584230522A5021288677 @default.
• W1584230522 hasAuthorship W1584230522A5086640700 @default.
• W1584230522 hasAuthorship W1584230522A5087133884 @default.
• W1584230522 hasAuthorship W1584230522A5089572133 @default.
• W1584230522 hasBestOaLocation W15842305221 @default.
• W1584230522 hasConcept C104317684 @default.
• W1584230522 hasConcept C147483822 @default.
• W1584230522 hasConcept C1491633281 @default.
• W1584230522 hasConcept C153911025 @default.
• W1584230522 hasConcept C155619193 @default.
• W1584230522 hasConcept C159654299 @default.
• W1584230522 hasConcept C16224149 @default.
• W1584230522 hasConcept C167454224 @default.
• W1584230522 hasConcept C185592680 @default.
• W1584230522 hasConcept C195616568 @default.
• W1584230522 hasConcept C203014093 @default.
• W1584230522 hasConcept C2777117008 @default.
• W1584230522 hasConcept C2777761686 @default.
• W1584230522 hasConcept C2779835222 @default.
• W1584230522 hasConcept C2780385752 @default.
• W1584230522 hasConcept C54009773 @default.
• W1584230522 hasConcept C542903549 @default.
• W1584230522 hasConcept C55493867 @default.
• W1584230522 hasConcept C85789140 @default.
• W1584230522 hasConcept C86803240 @default.
• W1584230522 hasConceptScore W1584230522C104317684 @default.
• W1584230522 hasConceptScore W1584230522C147483822 @default.
• W1584230522 hasConceptScore W1584230522C1491633281 @default.
• W1584230522 hasConceptScore W1584230522C153911025 @default.
• W1584230522 hasConceptScore W1584230522C155619193 @default.
• W1584230522 hasConceptScore W1584230522C159654299 @default.
• W1584230522 hasConceptScore W1584230522C16224149 @default.
• W1584230522 hasConceptScore W1584230522C167454224 @default.
• W1584230522 hasConceptScore W1584230522C185592680 @default.
• W1584230522 hasConceptScore W1584230522C195616568 @default.
• W1584230522 hasConceptScore W1584230522C203014093 @default.
• W1584230522 hasConceptScore W1584230522C2777117008 @default.
• W1584230522 hasConceptScore W1584230522C2777761686 @default.

• next